• There has been a recent cluster of spammers accessing BARFer accounts and posting spam. To safeguard your account, please consider changing your password. It would be even better to take the additional step of enabling 2 Factor Authentication (2FA) on your BARF account. Read more here.

Podcasts - For your listening pleasure

Status
Not open for further replies.
TWiV 689: COVID-19 clinical update #39 with Dr. Daniel Griffin

In TWiV 689 Daniel Griffin provides his weekly clinical report on COVID-19, including analysis of vitamin D levels in patients, information on Moderna and Pfizer vaccines, distribution plans suggested by ACIP, and more.

Links for this episode
 
TWiV 690: This is your brain on SARS-CoV-2

In Episode 690, TWiV reviews the difficulties in predicting species susceptibility to SARS-CoV-2 infection by only examining the ACE2 protein, and the olfactory mucosa as a portal of entry into the central nervous system in COVID-19 patients.

Links for this episode
 
TWiV 691: SciArt with Laura Splan

In Episode 691 SciArtist Laura Splan joins TWiV to reveal her transdisciplinary work that intersects science, technology, design and culture, then the team discuss an inverse correlation between mumps virus antibodies induced by MMR vaccine and COVID-19 severity, and whether ivermectin is indicated for treatment of COVID-19.

Links for this episode
 
TWiV 692: COVID-19 clinical update #40 with Dr. Daniel Griffin

In TWiV 692 Daniel Griffin provides his weekly clinical report on COVID-19, including the anticipated EUA for the Pfizer mRNA vaccine, mitigation strategies in early care and education settings, expressive aphasia, and much more.

Links for this episode
 
TWiV 693: Vax to the future

On TWiV 693, FDA EUA for Pfizer mRNA vaccine, efficacy of AstraZeneca ChAdOx1 COVID-19 vaccine, and an orally administered drug that blocks SARS-CoV-2 transmission in ferrets.

Links for this episode
 
TWiV 694: Mitigating COVID-19

In Episode 694, TWiV makes Bloomberg Business News 2020 Jealousy List, crushing of CDC revealed by insiders, seasonal influenza during the COVID-19 pandemic, FDA briefing documents from Moderna, and three-quarters attack rate of SARS-CoV-2 during an unmitigated epidemic in Brazil.

Links for this episode
 
TWiV 695: COVID-19 clinical update #41 with Dr. Daniel Griffin

In TWiV 695, Daniel Griffin provides his weekly clinical report on COVID-19, including thoughts on the first immunizations with Pfizer mRNA vaccine, the anticipated EUA for the Moderna vaccine, whether the vaccine prevents infection, not just disease, monoclonal antibody therapy, and much more.

Links for this episode
 
TWiV 696: Tear down that SARS-CoV-2 manuscript

In Episode 696, TWiV explains that COVID-19 is not harmless for young adults, FAA approval for Pfizer mRNA vaccine, lack of justification for the claim of reverse transcription of SARS-CoV-2 RNA and integration into the human genome, and lack of evidence for increased transmission by new variants in the UK.

Links for this episode
 
Last edited:
TWiV 697: The sky is NOT falling

In Episode 697, TWiV reviews the latest data on the UK variant of SARS-CoV-2, including some properties of the variant and why it is being closely studied, development of liver cancer in a participant in a adenovirus-associated virus gene therapy trial, and answers to listener questions.

Links for this episode
 
TWiV 698: COVID-19 clinical update #42 with Dr. Daniel Griffin

In TWiV 698, Daniel Griffin provides his weekly clinical report on COVID-19, including his own experience with vaccination, guidelines for vaccine distribution, reasons for under-utilization of monoclonal antibody therapy, and much more.

Links for this episode
 
TWiV 700: ‘Twas COVID and the aerosols

In Episode 700, TWiV reviews additional data on the UK variant of SARS-CoV-2, the distinct variant spreading in South Africa, association of afucosylated antiviral IgG with severe COVID-19, approval of AstraZeneca vaccine in the UK, and winners of the pandemic poem contest.

Links for this episode
 
TWiV 701: COVID-19 clinical update #43 with Dr. Daniel Griffin

In TWiV 701, Daniel Griffin’s final clinical report for 2020, he summarizes what we have learned about the clinical management of COVID-19 patients in the past year.

Links for this episode
 
TWiV 702: Year of the Pandemic

In TWiV's first episode of 2021, the complete TWiV team reviews compelling virology stories of 2020, and thanks the multitude of guests who have helped us to navigate the pandemic, and our many listeners who turn to us for scientific facts.

Links for this episode
 
TWiV 703: Does dose matter?

In Episode 703, a discussion of why modifying the dose schedule of the mRNA vaccines in the US is not a good idea, evidence that lower Ct values on hospital admission is associated with higher mortality, and dose-dependent response to SARS-CoV-2 infection of ferrets.

Links for this episode
 
TWiV 704: COVID-19 clinical update #44 with Dr. Daniel Griffin

In TWiV 704's COVID-19 clinical update, Daniel Griffin summarizes current status of vaccination in the US, discusses a study on convalescent sera from Argentina, use of remdesivir in patients with kidney disease, and provides further considerations on the use of Ct values in patient management.

Links for this episode
 
TWiV 705: Rocky Mountain COVID with Emily Travanty

In TWiV 705, Emily Travanty from the Colorado Department of Public Health and Environment joins TWiV to discuss how her laboratory was the first in the US to detect the SARS-CoV-2 variant VOC 202012/01.

Links for this episode
 
TWiV 706: Do as Dr. Fauci says

In Episode 706, TWiV answers listener questions about pandemic response, excess deaths in 25-44 year olds, vaccines, vaccines, and vaccines.

Links for this episode
 
TWiV 707: COVID-19 clinical update #45 with Dr. Daniel Griffin

In COVID-19 clinical update #45 (TWiV 707), Daniel Griffin discusses J&J Ad26 vaccine results, reactogenicity after the second dose of mRNA vaccines, expansion of vaccine eligibility, and the finding that encephalitis after SARS-CoV-2 infection is a cytokine release syndrome.

Links for this episode
 
TWiV 708: Alpaca llama full of nanobodies

In Episode 708, the TWiV team deconstructs CoronaVac, the inactivated SARS-CoV-2 vaccine produced by Sinovac Biotech, and production of multivalent camelid nanobodies that block infection with the virus and suppress selection of neturalization-resistant variants.

Links for this episode
 
TWiV 709: COVID cherry picking

In Episode 709, President Biden elevates his science advisor to his Cabinet, a review of the current flu season, the scientific goals of the WHO-convened Global Study of the Origins of SARS-CoV-2, and answers to listener questions.

Links for this episode
 
Status
Not open for further replies.
Back
Top